U.S. market Closed. Opens in 17 hours 9 minutes

INKT | MiNK Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/A2.70BN/AN/A689.63K
Cost of Revenue204.62K30.95B28.36B55.06KN/A
Gross Profit-204.62K-28.24B-28.36B-55.06K689.63K
Operating Expenses22.72M30.95M18.61M10.80M23.48M
Selling, General & Admin7.23M7.83M4.64M1.29M3.83M
Research & Development15.49M23.12M13.97M9.51M19.65M
Other Operating ExpensesN/A2.70M-9.53M-3.00M551.24K
Operating Income-22.92M-30.95M-28.36M-14.64M-22.28M
Other Expenses / Income463.24K2.96M-1.85M-1.60M-1.52M
Before Tax Income-22.46M-27.99M-30.21M-16.24M-23.80M
Income Tax Expenses3.00-3.21M-7.10M-560.38K2.11M
Net Income-22.46M-24.78M-23.11M-15.68M-25.91M
Interest ExpensesN/A253.32K2.43M2.44M1.56M
Basic Shares Outstanding34.36M33.67M33.48M33.09M33.09M
Diluted Shares Outstanding34.36M33.67M33.48M33.09M33.09M
EBITDA-22.72M-30.83M-28.06M-13.74M-22.20M
EBITDA Margin0.00%-1.14%0.00%0.00%-3,219.79%
EBIT-22.46M-27.74M-27.78M-13.80M-22.24M
EBIT Margin0.00%-1.03%0.00%0.00%-3,225.13%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙